IL10 and breast cancer: In B cells, in addition to increased basal pSTAT4 and pSmad2/3, we found reductions in IL-10 responsiveness through pSTAT3, increased IFNγ responsiveness through pSTAT1, and increased PD-L1, IL6Rα, and IL2Rβ expression were associated with BC status.